OSCR

Neuroprotective Effects of Lycopene in Parkinson's Disease Mice: Potential Modulation of DAT/SLC6A3-Mediated Dopaminergic Pathway.

Overview

Authors: Jun Xia1, Xin-Rui Fan2, Lin-Xia Lu1, Ci-Li Jifu1, Zhen-Yu Xu1, Jing-Tao Wang1
ORCID iDs: Jun Xia
  1. College of Basic Medical Sciences, Jiamusi University, Jiamusi 154007, China; (J.X.); (L.-X.L.); (C.-L.J.); (Z.-Y.X.)
  2. College of Biology and Agriculture, Jiamusi University, Jiamusi 154007, China
Institutions: Jiamusi University (China)
Journal: Nutrients, volume 18, issue 14, article 2234
Dates: received 30 May 2026; accepted 3 July 2026; published online 9 July 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3390/nu18142234 · PMID 42514303 · PMCID PMC13416145 · OpenAlex W7167838402
Open access: gold, a free copy (OpenAlex)
Categories: mouse (organism), Parkinson's (population)
Methods: Statistics, Smoothing, state filtering, decompositions, Connectivity
Keywords: neurodegeneration, lycopene, dopamine homeostasis, neuronal protection
MeSH: Dopamine*, Dopamine Plasma Membrane Transport Proteins*, Dopaminergic Neurons*, Lycopene*, Neuroprotective Agents*, Parkinson Disease*, Animals, Disease Models, Animal, Male, Mice, Mice, Inbred C57BL, Molecular Docking Simulation (* major topic)
Topic: Parkinson's Disease Mechanisms and Treatments (Clinical Neurology, Medicine), according to OpenAlex
Funding: Heilongjiang Provincial Science and Technology Department (2024ZX12C09)
Citations: not cited yet (Europe PMC); 59 references in the paper

Abstract

Background/Objectives: Lycopene (LYC), a natural lipid-soluble antioxidant extracted from dietary plants, possesses excellent neuroprotective and metabolic regulatory activities and has shown potential preventive and therapeutic effects on neurodegenerative diseases. However, its precise molecular mechanism against Parkinson’s disease (PD) remains incompletely clarified, which limits its further application. Methods: In this study, a PD mouse model was established, and a series of methods, including molecular docking, untargeted metabolomics, behavioral tests, and histopathological analysis, were used. Results: The results showed that LYC intervention not only improved the motor coordination ability of mice and reduced dopaminergic neuron damage but also reversed the metabolic disorders caused by the disease. Importantly, LYC can significantly increase the expression level of DAT/SLC6A3 in the midbrain region, and this is evident at both the gene and protein levels. Computational simulations and surface plasmon resonance results show that LYC can form stable complexes with the DAT/SLC6A3 protein and has a high affinity. Conclusions: This study explored the potential anti-PD effects of LYC from multiple perspectives and observed an association between elevated DAT/SLC6A3 levels and improved dopamine (DA) homeostasis after LYC intervention. These preliminary findings may offer new experimental clues for further mechanistic study and translational research on PD prevention and treatment.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

The data supporting this article are included as part of the Supplementary Information. The raw transcriptome sequencing data have been deposited in the NCBI GEO database (accession number: GSE336581 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE336581); URL: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE336581 (accessed on 26 May 2026); scheduled public release date: 24 June 2030). The full raw mass spectrometry data of untargeted metabolomics were submitted to the MetaboLights database (accession number: MTBLS14829; URL: https://www.ebi.ac.uk/metabolights/MTBLS14829 (accessed on 26 May 2026)). The complete raw mass spectrometry data for targeted neurotransmitter metabolomics were uploaded to MetaboLights (accession number: MTBLS14806; URL: https://www.ebi.ac.uk/metabolights/MTBLS14806 (accessed on 26 May 2026)).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 6 authors, 4 keywords, 12 MeSH terms, 1 funder, 59 references.

Cite

This paper

Xia, J., Fan, X.-R., Lu, L.-X., Jifu, C.-L., Xu, Z.-Y., & Wang, J.-T. (2026). Neuroprotective Effects of Lycopene in Parkinson's Disease Mice: Potential Modulation of DAT/SLC6A3-Mediated Dopaminergic Pathway. Nutrients, 18(14), 2234. https://doi.org/10.3390/nu18142234

BibTeX

@article{xia2026neuroprotective,
author = {Xia, Jun and Fan, Xin-Rui and Lu, Lin-Xia and Jifu, Ci-Li and Xu, Zhen-Yu and Wang, Jing-Tao},
title = {{Neuroprotective Effects of Lycopene in Parkinson's Disease Mice: Potential Modulation of DAT/SLC6A3-Mediated Dopaminergic Pathway}},
journal = {Nutrients},
year = {2026},
month = jul,
volume = {18},
number = {14},
pages = {2234},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2072-6643},
doi = {10.3390/nu18142234},
url = {https://doi.org/10.3390/nu18142234},
pmid = {42514303},
pmcid = {PMC13416145}
}

RIS

TY - JOUR
AU - Xia, Jun
AU - Fan, Xin-Rui
AU - Lu, Lin-Xia
AU - Jifu, Ci-Li
AU - Xu, Zhen-Yu
AU - Wang, Jing-Tao
TI - Neuroprotective Effects of Lycopene in Parkinson's Disease Mice: Potential Modulation of DAT/SLC6A3-Mediated Dopaminergic Pathway
T2 - Nutrients
J2 - Nutrients
PY - 2026
DA - 2026/07/09
VL - 18
IS - 14
SP - 2234
SN - 2072-6643
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/nu18142234
UR - https://doi.org/10.3390/nu18142234
LA - en
ER -

CSL-JSON

{
"id": "10.3390/nu18142234",
"type": "article-journal",
"title": "Neuroprotective Effects of Lycopene in Parkinson's Disease Mice: Potential Modulation of DAT/SLC6A3-Mediated Dopaminergic Pathway",
"container-title": "Nutrients",
"author": [
{
"family": "Xia",
"given": "Jun"
},
{
"family": "Fan",
"given": "Xin-Rui"
},
{
"family": "Lu",
"given": "Lin-Xia"
},
{
"family": "Jifu",
"given": "Ci-Li"
},
{
"family": "Xu",
"given": "Zhen-Yu"
},
{
"family": "Wang",
"given": "Jing-Tao"
}
],
"container-title-short": "Nutrients",
"volume": "18",
"issue": "14",
"page": "2234",
"DOI": "10.3390/nu18142234",
"PMID": "42514303",
"PMCID": "PMC13416145",
"ISSN": "2072-6643",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/nu18142234",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
9
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41598-026-50523-0 [code]
Mechanistic multiscale modeling identifies putative natural tri-target candidates of MAO-B, LRRK2 and A₂A for Parkinson's disease.
Journal: Scientific reports
In common: Parkinson's, 3 references
[2] doi:10.1186/s12864-026-13028-8
Selective hippocampal transcriptional adaptation to long-term cannabidiol exposure in mice.
Journal: BMC genomics
In common: mouse, 2 references
[3] doi:10.1186/s40035-026-00542-8
Bacteroides coprocola protects dopaminergic neurons in rotenone-induced Parkinson's disease mouse model by modulating gut microbiota dysbiosis and inhibiting the NLRP3 signaling pathway.
Journal: Translational neurodegeneration
In common: Parkinson's, mouse, 1 reference
[4] doi:10.1111/ejn.16180
Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's.
Journal: The European journal of neuroscience
In common: Parkinson's, mouse, 1 reference
[5] doi:10.1002/advs.202507323
NDST3-Induced Epigenetic Reprogramming Reverses Neurodegeneration in Parkinson's Disease.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
In common: Parkinson's, mouse, 1 reference
[6] doi:10.1038/s41531-023-00478-0
Deficiency of Perry syndrome-associated p150<sup>Glued</sup> in midbrain dopaminergic neurons leads to progressive neurodegeneration and endoplasmic reticulum abnormalities.
Journal: NPJ Parkinson's disease
In common: Parkinson's, mouse, 1 reference
[7] doi:10.1073/pnas.2619797123 [code]
Selective loss of primary cilia and neurotrophic signaling in G51D α-synuclein mice highlights a common pathway to Parkinson's disease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: Parkinson's, mouse, 1 reference
[8] doi:10.3389/fnins.2025.1546203 [code]
Exploring the relationship between <i>GBA1</i> host genotype and gut microbiome in the <i>GBA1</i> <sup>L444P/WT</sup> mouse model: implications for Parkinson's disease pathogenesis.
Journal: Frontiers in neuroscience
In common: Parkinson's, mouse, 1 reference
[9] doi:10.1038/s44319-025-00372-1 [code]
Transcriptional enhancers in human neuronal differentiation provide clues to neuronal disorders.
Journal: EMBO reports
In common: Parkinson's, 1 reference
[10] doi:10.3389/fnins.2026.1862571
Integrated bulk, single-cell, and spatial transcriptomic analyses prioritize NOTCH1 as a candidate gene associated with neurovascular and immune-related alterations in Parkinson's disease.
Journal: Frontiers in neuroscience
In common: Parkinson's, mouse, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.